Patent Yard Sign in
Canadian application, no grantCanada

Pharmaceutical composition for the treatment of acne vulgaris

CA 2113809 A1 · Owner: Miyazaki, Takashi · Inventors: Miyazaki, Takashi; Kamishita, Takuzo; Morishita, Chieko

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A pharmaceutical composition for the treatment of acne vulgaris, which comprises incorporating either one or both of crotamiton and glycol monosalyciate as the solvent for spironolactone into a composition containing spironolactone as the active ingredient in a conventional substrate for dermatologic drug.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 21, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 21, 2013.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 21, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 21, 1993
GrantedNo grant recorded
Term endedMay 21, 2013
Patent numberCA 2113809 A1
Classification (IPC)A61K47/16 +2 more

Timeline

Timeline From CIPO dates

1994199619982000200220042006200820102012Application filedMay 21, 1993Term endedMay 21, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.